Which Hedge Funds Own ABCL — Abcellera Biologics Inc. (Can)

12 of the hedge funds we track hold ABCL, worth $401.0M combined as of the Q2 2026 13F filings (preliminary, still landing).

Versus the prior quarter: 2 opened a new position, 4 added, 6 trimmed, 2 exited.

9 of those are hedged quant multi-strategy books, not directional conviction.

Insider buying at ABCL · All tracked funds